Brief: Acurx Pharmaceuticals Reports Q2 Loss Per Share Of $0.26
15/08/2022 12:33
Aug 15 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS SECOND QUARTER 2022
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.26
* ENDED Q2 ON JUNE 30, 2022, WITH CASH TOTALING $9.1 MILLION
COMPARED TO $13.1 MILLION AS OF DECEMBER 31, 2021
Source text for Eikon: ID:nPn25P6n5a
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program